Another study revealed that circST3GAL6 controlled apoptosis and autophagy via FOXP2-mediated transcriptional regulation of the MET axis via the miR-300/FOXP2 axis, which may represent a viable GC treatment target (Xu et al., 2022b). The gene discussed is FOXP2; the disease is gastric cancer.